Ocuphire Pharma, Inc.
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily prese…
Biotechnology
US, Farmington Hills [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Ocuphire Pharma, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDOcuphire Pharma, Inc. can't present revenue by segment